Literature DB >> 6993628

The effect of purified lipopolysaccharide on the bactericidal reaction of human serum complement.

R J Allen, G K Scott.   

Abstract

Escherichia coli ML308 225 was killed and lysed by human serum. Bacterial sensitivity to serum was maximal for organisms in the early-exponential phase of batch culture and declined as growth proceeded. Bacterial killing was dependent upon the complete complement sequence and the subsequent action of serum lysozyme caused bacteriolysis. Purified lipopolysaccharide from this organism bound to serum-sensitive bacteria and inhibited the bactericidal reaction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993628     DOI: 10.1099/00221287-117-1-65

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  10 in total

1.  Growth phase influences complement resistance of Bordetella pertussis.

Authors:  Michael G Barnes; Alison A Weiss
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Determination of serum bactericidal activity with the aid of luminous bacteria.

Authors:  M Barak; S Ulitzur; D Merzbach
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

3.  Analysis of outer membrane components of Escherichia coli ML308 225 and of a serum-resistant mutant.

Authors:  G L Tee; G K Scott
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

4.  Inhibition of serum bactericidal reaction by lipopolysaccharide.

Authors:  M Sansano; A M Reynard; R K Cunningham
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

5.  Effects of trospectomycin on serum sensitivity of Escherichia coli UC 9451.

Authors:  J I Cialdella; R G Ulrich; W F Liggett; L D Adams; V P Marshall
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

6.  Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.

Authors:  J A Odumeru; G M Wiseman; A R Ronald
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Protective effect of Porphyromonas gingivalis outer membrane vesicles against bactericidal activity of human serum.

Authors:  D Grenier; M Bélanger
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Comparison of the effects of different lipopolysaccharides on the serum bactericidal reactions of two strains of Escherichia coli.

Authors:  R J Allen; G K Scott
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

9.  Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.

Authors:  N L Schiller
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

10.  Outer membrane vesicle-mediated serum protection in Aggregatibacter actinomycetemcomitans.

Authors:  Mark Lindholm; Marjut Metsäniitty; Elisabeth Granström; Jan Oscarsson
Journal:  J Oral Microbiol       Date:  2020-04-08       Impact factor: 5.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.